Moore, Kelly R.
Stotz, Sarah A.
Terry, Martha Ann
Seely, Ellen W.
Gonzales, Kelly
Marshall, Gale
Nadeau, Kristen J.
Akers, Aletha
Garcia-Reyes, Yesenia
Charron-Prochownik, Denise
,
Brega, Angela
Chalmers, Laura
Fischl, Andrea
Garrow, Heather
Howe, Jean
McNealy, Kristie
O’Banion, Nancy
Powell, Jeff
Sereika, Susan
Stein, Howard
Thorkelson, Shelly
Uribe-Rios, Xochitl
Funding for this research was provided by:
National Institute of Nursing Research (NIH 1R01NR014831-01A1, NIH 1R01NR014831-01A1, NIH 1R01NR014831-01A1, NIH 1R01NR014831-01A1, NIH 1R01NR014831-01A1, NIH 1R01NR014831-01A1, NIH 1R01NR014831-01A1, NIH 1R01NR014831-01A1, NIH 1R01NR014831-01A1, NIH 1R01NR014831-01A1, NIH 1R01NR014831-01A1)
Article History
Received: 4 May 2022
Accepted: 12 July 2023
First Online: 1 August 2023
Declarations
:
: This study was approved by the Colorado Multiple Institutional Review Board. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki. A waiver of documentation of informed consent was granted by the Colorado Multiple Institutional Review Board.
: Written informed consent for publication of their clinical details and/or clinical images was obtained from the patient/parent/legal guardian/relative of the patient. A copy of the consent form is available for review by the Editor of this journal.
: Dr. Moore was a paid consultant for Novo Nordisk, Inc. <i>No other authors have any conflicts to declare.</i>